These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Social cognition in Wilson's disease: A new phenotype? Peyroux E; Santaella N; Broussolle E; Rigard C; Favre E; Brunet AS; Bost M; Lachaux A; Demily C PLoS One; 2017; 12(4):e0173467. PubMed ID: 28384152 [TBL] [Abstract][Full Text] [Related]
6. Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease. Shribman S; Burrows M; Convery R; Bocchetta M; Sudre CH; Acosta-Cabronero J; Thomas DL; Gillett GT; Tsochatzis EA; Bandmann O; Rohrer JD; Warner TT Mov Disord; 2022 Aug; 37(8):1728-1738. PubMed ID: 35723521 [TBL] [Abstract][Full Text] [Related]
7. Selective impairment of attentional networks of alerting in Wilson's disease. Han Y; Zhang F; Tian Y; Hu P; Li B; Wang K PLoS One; 2014; 9(6):e100454. PubMed ID: 24949936 [TBL] [Abstract][Full Text] [Related]
8. Comparative assessment of clinical rating scales in Wilson's disease. Volpert HM; Pfeiffenberger J; Gröner JB; Stremmel W; Gotthardt DN; Schäfer M; Weiss KH; Weiler M BMC Neurol; 2017 Jul; 17(1):140. PubMed ID: 28732478 [TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment and magnetic resonance imaging correlations in Wilson's disease. Frota NA; Barbosa ER; Porto CS; Lucato LT; Ono CR; Buchpiguel CA; Caramelli P Acta Neurol Scand; 2013 Jun; 127(6):391-8. PubMed ID: 23215772 [TBL] [Abstract][Full Text] [Related]
11. [Mild cognitive impairment and depressive symptoms in patients with Wilson's disease under long-term therapy]. Günther P; Hermann W Fortschr Neurol Psychiatr; 2012 Mar; 80(3):149-53. PubMed ID: 22407412 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of neurological Wilson's disease with corpus callosum abnormalities. Zhou ZH; Wu YF; Cao J; Hu JY; Han YZ; Hong MF; Wang GQ; Liu SH; Wang XM BMC Neurol; 2019 May; 19(1):85. PubMed ID: 31053106 [TBL] [Abstract][Full Text] [Related]
13. A neuropsychological comparison of siblings with neurological versus hepatic symptoms of Wilson's Disease. Arguedas D; Stewart J; Hodgkinson S; Batchelor J Neurocase; 2015; 21(2):154-61. PubMed ID: 24499483 [TBL] [Abstract][Full Text] [Related]
14. Effects of copper toxicity on response inhibition processes: a study in Wilson's disease. Stock AK; Reuner U; Gohil K; Beste C Arch Toxicol; 2016 Jul; 90(7):1623-30. PubMed ID: 26438404 [TBL] [Abstract][Full Text] [Related]
15. A novel Global Assessment Scale for Wilson's Disease (GAS for WD). Aggarwal A; Aggarwal N; Nagral A; Jankharia G; Bhatt M Mov Disord; 2009 Mar; 24(4):509-18. PubMed ID: 19115420 [TBL] [Abstract][Full Text] [Related]